| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukins | 18 | 2022 | 108 | 5.340 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2018 | 100 | 2.150 |
Why?
|
| Bacterial Toxins | 4 | 2022 | 265 | 1.760 |
Why?
|
| Lymphocytes | 5 | 2023 | 83 | 1.760 |
Why?
|
| Antigens, Bacterial | 4 | 2022 | 159 | 1.440 |
Why?
|
| Immunity, Innate | 7 | 2023 | 205 | 1.270 |
Why?
|
| Inflammation | 7 | 2023 | 601 | 1.210 |
Why?
|
| Mice | 30 | 2023 | 4406 | 1.120 |
Why?
|
| Th17 Cells | 3 | 2020 | 32 | 1.080 |
Why?
|
| Animals | 38 | 2023 | 9962 | 1.040 |
Why?
|
| Cell Differentiation | 6 | 2020 | 395 | 1.030 |
Why?
|
| Receptors, Interleukin | 2 | 2021 | 12 | 0.890 |
Why?
|
| Putrescine | 1 | 2023 | 1 | 0.850 |
Why?
|
| Polyamines | 1 | 2023 | 12 | 0.850 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2011 | 56 | 0.850 |
Why?
|
| Hepatocytes | 2 | 2016 | 68 | 0.810 |
Why?
|
| Listeria monocytogenes | 8 | 2007 | 58 | 0.800 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 121 | 0.790 |
Why?
|
| Bacillus anthracis | 3 | 2017 | 146 | 0.770 |
Why?
|
| Clostridium Infections | 1 | 2022 | 66 | 0.760 |
Why?
|
| Colitis | 5 | 2016 | 53 | 0.730 |
Why?
|
| Cytokines | 6 | 2022 | 439 | 0.720 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 11 | 0.720 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2011 | 39 | 0.710 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 69 | 0.690 |
Why?
|
| Signal Transduction | 10 | 2020 | 1344 | 0.660 |
Why?
|
| Colon | 5 | 2018 | 119 | 0.660 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 57 | 0.650 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 110 | 0.650 |
Why?
|
| Lymphocyte Activation | 9 | 2023 | 204 | 0.640 |
Why?
|
| Immunity, Mucosal | 2 | 2018 | 4 | 0.640 |
Why?
|
| Hypoxia | 2 | 2016 | 85 | 0.640 |
Why?
|
| Ovalbumin | 2 | 2018 | 7 | 0.630 |
Why?
|
| Cholera Toxin | 1 | 2018 | 6 | 0.620 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 93 | 0.620 |
Why?
|
| Dexamethasone | 1 | 2018 | 53 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 11 | 2020 | 1475 | 0.590 |
Why?
|
| Bacterial Proteins | 6 | 2022 | 474 | 0.570 |
Why?
|
| Listeriosis | 5 | 2007 | 40 | 0.560 |
Why?
|
| Lipocalin-2 | 1 | 2016 | 6 | 0.560 |
Why?
|
| Anthrax | 1 | 2017 | 85 | 0.550 |
Why?
|
| Interleukin-17 | 3 | 2018 | 51 | 0.520 |
Why?
|
| Virulence Factors | 2 | 2005 | 45 | 0.470 |
Why?
|
| Interleukin-23 | 3 | 2023 | 8 | 0.460 |
Why?
|
| Colonic Diseases | 1 | 2013 | 10 | 0.430 |
Why?
|
| Gastrointestinal Tract | 2 | 2023 | 34 | 0.400 |
Why?
|
| Autoimmune Diseases | 3 | 2010 | 162 | 0.400 |
Why?
|
| Mice, Knockout | 9 | 2018 | 782 | 0.400 |
Why?
|
| Down-Regulation | 3 | 2016 | 197 | 0.400 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 3 | 2005 | 6 | 0.380 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2009 | 91 | 0.380 |
Why?
|
| Interleukin-12 | 1 | 2011 | 17 | 0.370 |
Why?
|
| Humans | 18 | 2023 | 26846 | 0.370 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 143 | 0.330 |
Why?
|
| Killer Cells, Natural | 1 | 2008 | 61 | 0.310 |
Why?
|
| Gene Expression | 3 | 2020 | 406 | 0.310 |
Why?
|
| Immunologic Memory | 3 | 2011 | 58 | 0.310 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 86 | 0.300 |
Why?
|
| Hepatitis | 1 | 2007 | 7 | 0.300 |
Why?
|
| T-Lymphocytes | 3 | 2012 | 274 | 0.280 |
Why?
|
| Bacteria | 2 | 2023 | 263 | 0.260 |
Why?
|
| Cell Line | 4 | 2016 | 672 | 0.250 |
Why?
|
| Dendritic Cells | 3 | 2012 | 142 | 0.230 |
Why?
|
| Enterobacteriaceae | 1 | 2023 | 8 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2016 | 970 | 0.220 |
Why?
|
| Intestinal Mucosa | 3 | 2016 | 186 | 0.210 |
Why?
|
| Ornithine Decarboxylase | 1 | 2023 | 8 | 0.210 |
Why?
|
| Edema | 1 | 2022 | 18 | 0.200 |
Why?
|
| Monocytes | 1 | 2023 | 132 | 0.200 |
Why?
|
| Cyclic AMP | 1 | 2022 | 80 | 0.190 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 44 | 0.190 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2012 | 34 | 0.190 |
Why?
|
| Flagellin | 2 | 2012 | 9 | 0.190 |
Why?
|
| Skin | 1 | 2021 | 140 | 0.180 |
Why?
|
| Smad2 Protein | 1 | 2020 | 16 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 77 | 0.180 |
Why?
|
| Macrophages | 1 | 2023 | 274 | 0.180 |
Why?
|
| Virulence | 3 | 2017 | 144 | 0.170 |
Why?
|
| Interferon-gamma | 2 | 2018 | 102 | 0.170 |
Why?
|
| Glycolysis | 1 | 2020 | 82 | 0.170 |
Why?
|
| Interleukin-10 | 2 | 2011 | 68 | 0.170 |
Why?
|
| Oxygen | 2 | 2016 | 218 | 0.170 |
Why?
|
| Liver | 1 | 2021 | 415 | 0.160 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2009 | 30 | 0.160 |
Why?
|
| Interleukin-13 | 1 | 2018 | 6 | 0.150 |
Why?
|
| Administration, Rectal | 1 | 2018 | 5 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 5 | 2012 | 264 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2018 | 114 | 0.150 |
Why?
|
| Immunization | 1 | 2018 | 118 | 0.150 |
Why?
|
| NF-kappa B | 1 | 2018 | 187 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2016 | 240 | 0.140 |
Why?
|
| Microbiota | 1 | 2018 | 79 | 0.140 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 5 | 0.140 |
Why?
|
| Cytoprotection | 1 | 2016 | 24 | 0.140 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2016 | 12 | 0.130 |
Why?
|
| Female | 5 | 2020 | 14466 | 0.130 |
Why?
|
| Mucins | 1 | 2016 | 22 | 0.130 |
Why?
|
| Inflammasomes | 2 | 2012 | 20 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2016 | 60 | 0.130 |
Why?
|
| Glycosylphosphatidylinositols | 2 | 2005 | 8 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 1394 | 0.120 |
Why?
|
| Male | 3 | 2020 | 12874 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2012 | 33 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 133 | 0.120 |
Why?
|
| Toll-Like Receptor 5 | 2 | 2012 | 5 | 0.110 |
Why?
|
| Helicobacter | 1 | 2013 | 1 | 0.110 |
Why?
|
| Antigens | 2 | 2012 | 66 | 0.110 |
Why?
|
| Lactobacillus | 1 | 2013 | 14 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2013 | 35 | 0.110 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2003 | 45 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 57 | 0.100 |
Why?
|
| Adoptive Transfer | 3 | 2007 | 25 | 0.100 |
Why?
|
| Metagenome | 1 | 2013 | 50 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2013 | 282 | 0.100 |
Why?
|
| West Nile Fever | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cell Communication | 1 | 2013 | 66 | 0.100 |
Why?
|
| West Nile virus | 1 | 2012 | 20 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 114 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 74 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 37 | 0.100 |
Why?
|
| Base Sequence | 1 | 2013 | 573 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 318 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 114 | 0.100 |
Why?
|
| Intestines | 1 | 2012 | 117 | 0.100 |
Why?
|
| Phosphoinositide Phospholipase C | 3 | 2005 | 5 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 121 | 0.090 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 17 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 324 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2011 | 19 | 0.090 |
Why?
|
| Berberine | 2 | 2000 | 2 | 0.090 |
Why?
|
| Plants, Medicinal | 2 | 2000 | 17 | 0.090 |
Why?
|
| Twin Studies as Topic | 1 | 2010 | 2 | 0.090 |
Why?
|
| Flavonoids | 2 | 2000 | 30 | 0.090 |
Why?
|
| Vancomycin Resistance | 1 | 2010 | 4 | 0.090 |
Why?
|
| Enterococcus | 1 | 2010 | 19 | 0.090 |
Why?
|
| Ligands | 2 | 2012 | 168 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 408 | 0.080 |
Why?
|
| Staphylococcus aureus | 2 | 2000 | 111 | 0.080 |
Why?
|
| Spleen | 3 | 2005 | 109 | 0.080 |
Why?
|
| Biological Therapy | 1 | 2009 | 5 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2009 | 15 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 486 | 0.080 |
Why?
|
| Immunity, Active | 1 | 2008 | 4 | 0.080 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2010 | 90 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 238 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2012 | 240 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 152 | 0.070 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2007 | 2 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 253 | 0.070 |
Why?
|
| Models, Animal | 1 | 2007 | 129 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2007 | 189 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2005 | 13 | 0.060 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 22 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2007 | 646 | 0.060 |
Why?
|
| Bacillus thuringiensis | 1 | 2005 | 19 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 83 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 109 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2003 | 197 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2005 | 152 | 0.060 |
Why?
|
| Bacillus cereus | 1 | 2005 | 58 | 0.060 |
Why?
|
| Cytochalasin B | 1 | 2004 | 2 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 7 | 0.060 |
Why?
|
| Time Factors | 2 | 2012 | 1562 | 0.060 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2003 | 26 | 0.060 |
Why?
|
| Cell Death | 1 | 2004 | 110 | 0.060 |
Why?
|
| Bystander Effect | 1 | 2003 | 16 | 0.060 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2023 | 11 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2002 | 10 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2002 | 23 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2002 | 62 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2002 | 118 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2001 | 8 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2001 | 23 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2001 | 28 | 0.050 |
Why?
|
| Vaccination | 1 | 2002 | 167 | 0.050 |
Why?
|
| Kidney | 1 | 2023 | 275 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2010 | 496 | 0.050 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2012 | 6 | 0.050 |
Why?
|
| Chlorophyll | 1 | 2000 | 10 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2000 | 20 | 0.040 |
Why?
|
| Cell Movement | 2 | 2012 | 353 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2013 | 75 | 0.040 |
Why?
|
| Silymarin | 1 | 2000 | 6 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2012 | 115 | 0.040 |
Why?
|
| Proteins | 2 | 2012 | 244 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2005 | 1036 | 0.040 |
Why?
|
| Glycosylation | 1 | 2016 | 69 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2007 | 6 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2007 | 6 | 0.030 |
Why?
|
| Phenotype | 2 | 2012 | 667 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2009 | 771 | 0.030 |
Why?
|
| Models, Biological | 2 | 2010 | 446 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 49 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 674 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 143 | 0.030 |
Why?
|
| Genes, APC | 1 | 2012 | 14 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2012 | 16 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 129 | 0.030 |
Why?
|
| Virus Internalization | 1 | 2012 | 12 | 0.030 |
Why?
|
| Disease Resistance | 1 | 2012 | 18 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2012 | 4 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2012 | 62 | 0.020 |
Why?
|
| Weight Loss | 1 | 2012 | 72 | 0.020 |
Why?
|
| Chemokines | 1 | 2012 | 73 | 0.020 |
Why?
|
| Vaccines | 1 | 2012 | 30 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2012 | 42 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2012 | 95 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 134 | 0.020 |
Why?
|
| Neutrophils | 1 | 2012 | 177 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 116 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 160 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 84 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2009 | 33 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 59 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2010 | 66 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 453 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 466 | 0.020 |
Why?
|
| L-Selectin | 1 | 2007 | 11 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2007 | 39 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2007 | 37 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2007 | 49 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2007 | 53 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 699 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2007 | 78 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 155 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2007 | 263 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2007 | 153 | 0.020 |
Why?
|
| Autoantigens | 1 | 2007 | 212 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 394 | 0.020 |
Why?
|
| Vacuoles | 1 | 2005 | 10 | 0.020 |
Why?
|
| Bacteroides fragilis | 1 | 2005 | 3 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 38 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2005 | 53 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2005 | 110 | 0.020 |
Why?
|
| Immune System | 1 | 2005 | 29 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 130 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2005 | 78 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 93 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2003 | 7 | 0.010 |
Why?
|
| Vaccines, Synthetic | 1 | 2003 | 8 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 14 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2003 | 32 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 627 | 0.010 |
Why?
|
| Carrier State | 1 | 2001 | 8 | 0.010 |
Why?
|
| Galactosyltransferases | 1 | 2001 | 16 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 820 | 0.010 |
Why?
|
| Tyrosine | 1 | 2001 | 90 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 538 | 0.010 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 2000 | 2 | 0.010 |
Why?
|
| Bacteremia | 1 | 2001 | 80 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2000 | 18 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2000 | 29 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 36 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 34 | 0.010 |
Why?
|
| Colorado | 1 | 2000 | 47 | 0.010 |
Why?
|
| Biological Assay | 1 | 2000 | 35 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2000 | 54 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2000 | 55 | 0.010 |
Why?
|
| Ethidium | 1 | 2000 | 5 | 0.010 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2000 | 13 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 560 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2000 | 61 | 0.010 |
Why?
|
| Fluorescence | 1 | 2000 | 48 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2000 | 135 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 100 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 111 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 176 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 400 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2000 | 239 | 0.010 |
Why?
|